Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

NCT00652899 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Withdrawn due to toxicity

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: Allopurinol
DRUG: Cyclophosphamide
DRUG: Fludarabine phosphate
RADIATION: total-body irradiation
BIOLOGICAL: Allogeneic natural killer cells
BIOLOGICAL: Aldesleukin

Sponsor

Masonic Cancer Center, University of Minnesota